Average Co-Inventor Count = 8.73
ph-index = 3
The patent ph-index is calculated by counting the number of publications for which an author has been cited by other authors at least that same number of times.
Company Filing History:
1. Cymabay Therapeutics, Inc. (4 from 43 patents)
2. Metabolex, Inc. (4 from 41 patents)
8 patents:
1. 9925189 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
2. 9737537 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
3. 8975258 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
4. 8921350 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
5. 8288384 - Heterocyclic receptor agonists for the treatment of diabetes and metabolic disorders
6. 8227495 - 2,4-disubsituted thiazoles and pharmaceutical compositions thereof
7. 7638541 - 5-ethyl-2-{4-[4-(4-tetrazol-1-yl-phenoxymethyl)-thiazol-2-yl]-piperidin-1-yl}-pyrimidine
8. 7556930 - CD39L3 and its role in diabetes